Session Details
[OE1]Oral English Session 1 Cancer Genetics
Thu. Dec 15, 2022 9:20 AM - 10:10 AM JST
Thu. Dec 15, 2022 12:20 AM - 1:10 AM UTC
Thu. Dec 15, 2022 12:20 AM - 1:10 AM UTC
Room 7
Chairs：Hidewaki Nakagawa (RIKEN IMS Laboratory for Cancer Genomics), Yoshinori Murakami (Division of Molecular Pathology, The Institute of Medical Science, The University of Tokyo)
[OE1-1]Predicting the number of BRCA tests based on 1,047 breast cancer cases and their accessibility to clinical genetics
○Kouji Ohta1, Tomoko Itoh1, Ikue Hata2, Jun Kato2, Genrei Ohta2 (1.Department of Surgery, Fukui Prefectural Hospital, Fukui, Japan, 2.Department of Clinical Genetics, Fukui Prefectural Hospital, Fukui, Japan)
[OE1-2]Characterization of URST7 as a novel prognostic biomarker and therapeutic target for breast cancer
○Regina Mbugua1,2, Atsushi Takano1,2,3, Bayarbat Tsevegjav1,2, Yohei Miyagi4, Yataro Daigo1,2,3 (1.Dep. Med. Oncol. & Cancer Ctr., Shiga Univ. Med. Sci. Otsu, Shiga, Japan, 2.Ctr. Advanced Med. against Cancer, Shiga Univ. of Med. Sci., Otsu, Shiga, Japan, 3.Ctr. Antibody and Vaccine Ther, Inst. Med. Sci., Univ. Tokyo, Tokyo, Japan, 4.Mol. Pathol. & Genet. Div., Kanagawa Cancer Ctr., Kanagawa, Japan)
[OE1-3]HJURP as a prognostic biomarker and therapeutic target for oral cancer
○Bayarbat Tsevegjav1,2, Atsushi Takano1,2,3, Ming Zhu1,2, Yoshihiro Yoshitake4, Masanori Shinohara4, Yataro Daigo1,2,3 (1.Department of Medical Oncology and Cancer Center, Shiga University of Medical Science, Shiga, Japan, 2.Center for Advanced Medicine against Cancer, Shiga University of Medical Science, 3.Center for Antibody and Vaccine Therapy, Institute of Medical Science, The University of Tokyo, 4.Department of Oral and Maxillofacial Surgery, Kumamoto University)
[OE1-4]Withdrawn
[OE1-5]The impact of common germline risk on somatic alterations and clinical features across cancers
○Shinichi Namba1, Yuki Saito2,3, Yasunori Kogure2, Tatsuo Masuda1,4,5, Yukinori Okada1,6,7,8, Keisuke Kataoka2,9 (1.Department of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Japan, 2.Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan, 3.Department of Gastroenterology, Keio University School of Medicine, Tokyo, Japan, 4.Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan, 5.StemRIM Institute of Regeneration-Inducing Medicine, Osaka University, Osaka, Japan, 6.Department of Genome Informatics, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan, 7.Laboratory for Systems Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan, 8.Laboratory of Statistical Immunology, Immunology Frontier Research Center (WPI-IFReC), Osaka University, Suita, Japan, 9.Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan)